Atossa Therapeutics (ATOS)
NASDAQ:ATOS
Holding ATOS?
Track your performance easily

Atossa Therapeutics (ATOS) Financial Statements

2,082 Followers

Atossa Therapeutics Financial Overview

Atossa Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.206; its P/E ratio is -6.88; Atossa Therapeutics is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -6.05M$ -5.88M$ -7.75M$ -6.23M$ -9.83M
EBITDA$ -6.04M$ -5.87M$ -7.74M$ -6.23M$ -9.83M
Net Income Common Stockholders$ -6.05M$ -5.90M$ -7.76M$ -6.23M$ -9.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 79.53M$ 83.96M$ 88.46M$ 94.03M$ 99.50M
Total Assets$ 85.86M$ 91.09M$ 96.25M$ 101.69M$ 108.36M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -79.53M$ -83.96M$ -88.46M$ -94.03M$ -99.50M
Total Liabilities$ 5.70M$ 5.33M$ 5.24M$ 3.44M$ 3.48M
Stockholders Equity$ 80.16M$ 85.76M$ 91.02M$ 98.25M$ 104.88M
Cash Flow-
Free Cash Flow$ -4.53M$ -4.70M$ -5.57M$ -3.88M$ -4.48M
Operating Cash Flow$ -4.53M$ -4.70M$ -5.57M$ -3.88M$ -4.46M
Investing Cash Flow$ -3.00K$ -6.00K-$ -1.00K$ -13.00K
Financing Cash Flow$ 100.00K$ 204.00K-$ -1.48M-
Currency in USD

Atossa Therapeutics Earnings and Revenue History

Atossa Therapeutics Debt to Assets

Atossa Therapeutics Cash Flow

Atossa Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis